Investment is being directed by the Round 3 Clinical Project Investment Principles which build on Queensland Genomics Round 1 and Round 2, and have been approved by Queensland Health.

Round 3 Clinical projects may include a focus on patient cohorts and/or disease areas to build evidence in:

  • precision medicine,
  • pharmacogenomics, and/or
  • population/preventative health.

Queensland Clinical Networks stream

Queensland Genomics is currently working with Queensland’s clinical networks to identify potential Round 3 clinical projects as a targeted expression of interest activity.

Potential projects will undergo the assessment process before review and recommendation by the Queensland Genomics’ Governance Oversight Group ahead of submission to Queensland Health Director-General for approval.

How do I apply?

Queensland Genomics is working with Queensland’s clinical networks to identify potential Round 3 clinical projects as a targeted expression of interest activity.

 

Reanalysis stream

Due to the interest from the clinical networks, the reanalysis stream is no longer required.

 

Selection Process (Non-Cancer)

Round 3 Clinical Projects will be selected using a streamlined version of the Round 2 selection process:

  • Targeted Expression of Interest (August-September)
  • Project assessment considering Clinical Utility, Partnerships, Feasibility (September-October)
  • Contracting and project start up (October-November)

Timing

The Round 3 clinical project selection process is underway from August to October 2019.

Queensland Genomics will prepare the Round 3 Clinical Projects Business Case for Governance Oversight Group endorsement in October 2019 prior to Director-General approval. Project contracting and start up will begin following Director-General approval.

All Round 3 projects must align to Queensland Genomics’ end date of 30 June 2021.

Criteria

Essential criteria for clinical projects:

Highly desirable criteria for clinical projects:

  • Leverages Queensland Genomics Round 2 investment to look at precision medicine applications that expand capability for analysis or reanalysis for pharmacogenomics and functional genomics with a diagnostics capability
  • Established research partnership.

 

For more information

Email projects@queenslandgenomics.org with any questions about the Round 3 Clinical Project Selection Process.

To stay up to date on the Round 3 project selection process sign up for the Queensland Genomics eNewsletter.